As of January 2025, Dawnrays Pharmaceutical has a market cap of $231.70M. This makes Dawnrays Pharmaceutical the world's 15638th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $218.18M | 7.62% |
2023 | $202.74M | -21.05% |
2022 | $256.80M | -20.36% |
2021 | $322.45M | 20.14% |
2020 | $268.39M | -2.80% |
2019 | $276.11M | -2.72% |
2018 | $283.83M | -31.15% |
2017 | $412.23M | -8.37% |
2016 | $449.88M | -22.59% |
2015 | $581.18M | 21.62% |
2014 | $477.88M | 0.41% |
2013 | $475.95M | 220.13% |
2012 | $148.67M | -31.56% |
2011 | $217.22M | -38.36% |
2010 | $352.38M | 192.00% |
2009 | $120.68M | 78.57% |
2008 | $67.58M | -12.50% |
2007 | $77.23M | 1.27% |
2006 | $76.27M | 27.42% |
2005 | $59.86M | -1.59% |
2004 | $60.82M | -21.25% |
2003 | $77.23M | - |